SIMCERE PHARMACEUTICAL GRP LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 2096 for the last semiannual is 3.37 B HKD, and it's 3.27% lower compared to the previous semiannual. The net income of H1 24 is 494.78 M HKD.